TOKYO -- About 90% of patients with "obesity disease" in Japan perceive the medical condition as a personal responsibility, ...
Eli Lilly has opened up a second market for its new Alzheimer's disease therapy Kisunla, after Japan followed the US in approving the drug. Kisunla (donanemab) is the second in a new generation of ...
Pharmacists will be able to substitute Eli Lilly’s insulin Lispro for Sanofi’s Humalog. Concerns over Verzenio in Japan However there were worries for Lilly in Japan, after it was reported ...
“It was a good thing I chose Licca-chan.” Nishimura works at Eli Lilly Japan K.K., a pharmaceutical company in Kobe. Since April 2021, when the company developed a curative drug for alopecia ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...